Your browser doesn't support javascript.
loading
Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts.
Catalano, Luca; Aminzadeh-Gohari, Sepideh; Weber, Daniela D; Poupardin, Rodolphe; Stefan, Victoria E; Smiles, William J; Tevini, Julia; Feichtinger, René G; Derdak, Sophia; Bilban, Martin; Bareswill, Stefan; Heimesaat, Markus M; Kofler, Barbara.
Afiliación
  • Catalano L; Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Aminzadeh-Gohari S; Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Weber DD; Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Poupardin R; Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Cell Therapy Institute, Paracelsus Medical University, 5020 Salzburg, Austria.
  • Stefan VE; Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Smiles WJ; Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Tevini J; Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Feichtinger RG; Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
  • Derdak S; Core Facilities, Medical University of Vienna, 1090 Vienna, Austria.
  • Bilban M; Core Facilities, Medical University of Vienna, 1090 Vienna, Austria.
  • Bareswill S; Department of Laboratory Medicine, Medical University of Vienna, 1090 Vienna, Austria.
  • Heimesaat MM; Gastrointestinal Microbiology Research Group, Institute of Microbiology, Infectious Diseases and Immunology, Charité-University Medicine Berlin, Corporate Member of Free University Berlin, Humboldt University Berlin and Berlin Institute of Health, 12203 Berlin, Germany.
  • Kofler B; Gastrointestinal Microbiology Research Group, Institute of Microbiology, Infectious Diseases and Immunology, Charité-University Medicine Berlin, Corporate Member of Free University Berlin, Humboldt University Berlin and Berlin Institute of Health, 12203 Berlin, Germany.
Metabolites ; 13(8)2023 Aug 03.
Article en En | MEDLINE | ID: mdl-37623854
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Metabolites Año: 2023 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Metabolites Año: 2023 Tipo del documento: Article País de afiliación: Austria